A drug against hypertension photo

Тип статьи:
Авторская



A drug against hypertension photo



A drug against hypertension photo


Diuretiko (Diuretika) ay nagpapataas ng pag-ihi ng katawan, na nagreresulta sa pagbaba ng presyon ng dugo. Simpleng paliwanag: Ang tuloy-tuloy na pag-ihi ng katawan ay nagdudulot ng pagbaba ng dami ng plasma sa dugo at sa gayon ay mas kaunting likido sa mga ugat — bumababa ang presyon sa mga pader ng ugat.

ЧИТАТЬ ДАЛЕЕ ...









































High blood pressure is under control with Cardio BalanceDo you often feel tired, have headaches or dizziness? These symptoms can be signs of high blood pressure is a silent danger, the loaded vessels, your heart and your blood. Cardio Balance helps your body to keep the blood pressure stable. Developed on the Basis of innovative research and clinically tested, it supports your cardiovascular System gently and effectively.Why Cardio Balance?Lowers blood pressure reliably on a healthy value.In effect already after a short period of time — a tangible relief from the very beginning.A good safety and tolerability profile of a minimum of side effects.It is recommended by Doctors — trust on the Basis of studies.Your path to a better quality of life:With Cardio Balance, you can feel more energy, your everyday stress-free master and your risk for heart and vascular diseases is significantly lower.Talk with your doctor! He can tell you whether Cardio Balance is the right product for you.Warning: medicine only after doctor's prescription to take. Before use, always read the package leaflet.

Ang pagkontrol sa presyon ay isang napakahalagang gawain, dahil ang pag-inom ng mga tableta na nakakatulong sa pagpapanatili ng normal na mga indikador ay maaaring magbigay ng araw-araw na komportableng buhay, upang maiwasan ang panganib ng hypertensive crisis, atake sa puso, at stroke. Ang mga gamot para sa kontrol ng presyon ay medyo malawakang makukuha sa mga botika, pero tanging ang doktor lang ang makakapili ng tamang gamot na angkop sa therapy. Lahat ng grupo ng gamot para pababain ang presyon ay may iba't ibang mekanismo ng epekto, side effects, at may kaunting posibilidad ng pagkadepende. Ang tamang pagpili ng gamot ay nagbibigay ng mabilis at tuloy-tuloy na resulta, at ang eksperimento sa sarili sa pag-inom ng gamot ay may mataas na posibilidad ng biglaang karamdaman, sakit sa puso at daluyan ng dugo, at sa matinding kaso, maaaring magdulot ng kamatayan. A drug against hypertension photo. Nililinis ang mga ugat na kailangang alagaan mula sa deposito at pinananatili ang kinakailangang lakas ng tibok ng puso!

Methods of treatment of cardiovascular diseases

Property Cardiovascular Diseases

Risk factors for cardiovascular diseases short

Germany Cardiovascular Diseases

www.dakmet.com.pl/upload/8088-medicines-for-high-blood-pressure-daily-actions.xml

www.comobrew.com/newsite/images/user_uploads/scale-risk-of-cardiovascular-disease.xml

Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. Cardio Balance is formulated and made after years of rigorous research and clinical study of the ingredients. The unique combination of each ingredient brings out optimal effectiveness in supporting heart and blood pressure.


Google
Google

Vitagerpavak and its relevance for cardiac and vascular disease: An analysis of current research resultsThe treatment and prevention of heart and vascular diseases and represents one of the most important challenges of modern medicine. In this context, immunological approaches are gaining increasing interest, in particular, the possible role of vaccines as Vitagerpavak in the influence of risk factors for cardiovascular disease.Vitagerpavak is a vaccine, which was originally developed for the prophylaxis of herpes simplex infections. It contains inactivated virus particles of the Herpes simplex Virus (HSV) and to strengthen the immune response against these pathogens. Recent studies suggest, however, that a chronic infection with HSV and other herpes viruses may be associated with an increased risk for atherosclerotic diseases.Pathophysiological BasesAtherosclerosis, the basis of many cardiovascular diseases, is no longer valid today only as a lipid-induced vascular changes. Inflammatory processes play a Central role in the progression of Plaque formation and in the instability of progression. Herpes viruses, such as HSV‑1 and cytomegalovirus (CMV) can cause various tissues, including the vascular wall, persist, and there is a chronic, subclinical inflammation.This chronic inflammation can exert the following effects:Activation of macrophages and T‑cells in the vascular wall;Increased production of proinflammatory cytokines (e.g., TNF‑α, IL‑6);Impairment of endothelial function;Amplification of the Oxidation of LDL cholesterol.Potential mechanisms of action of VitagerpavakVaccination with Vitagerpavak a specific stimulated immune response against HSV. A possible protective effect against cardiovascular disease could pass through the following mechanisms:Reduction of viral load: An effective immune response can prevent the reactivation and spread of HSV. As a result, the chronic inflammation is attenuated in the vascular wall.Modulation of systemic inflammation: A controlled immune response could affect the balance between pro‑ and anti-inflammatory cytokines positively.Protection of the endothelial cells By the reduction of viral damage to the function of the vascular endothelium could be preserved, which delays the development of atherosclerosis.Previous Research ResultsEpidemiological studies show a correlation between serological Evidence of HSV infection and the Occurrence of coronary heart disease (CHD). In animal models, it could be demonstrated that vaccination against CMV may reduce the development of Atheroskleroseplaquen. Whether these results are directly on Vitagerpavak and HSV-transferable, must be investigated in clinical intervention studies.Conclusions and OutlookThe vaccine Vitagerpavak also could represent his primary anti — viral effect — a new approach to the prevention of heart and vascular diseases. The underlying mechanism is the reduction of a virus-induced chronic inflammation, which contributes to atherosclerosis would be.Currently, randomized, controlled clinical trials that demonstrate the direct cardioprotective effect of Vitagerpavak missing. Further research is necessary to evaluate the efficacy and safety of such a prevention approach. The study of the interactions between viral infections, the immune system, and cardiovascular disease remains a promising field of research.

Нет комментариев. Ваш будет первым!
Используя этот сайт, вы соглашаетесь с тем, что мы используем файлы cookie.